How to Buy Anthropic Stock (ANT) in Europe
Anthropic listed on Nasdaq as ANT on 19 November 2026. How to buy it from Europe now the IPO window has closed, what brokers charge, and the risks.
Zune.Money Team8 min read
Anthropic, the company behind the Claude AI models, started trading on the Nasdaq under the ticker ANT on 19 November 2026. It priced its IPO at $83 a share, above the $70 to $78 range it had marketed, and closed its first day at $97.17, up about 17%. If you want to know how to buy Anthropic stock in Europe, the answer today is simple: open a broker with US market access, search ANT, and buy it like any other US share.
The IPO subscription window is the part you have missed. Retail investors in ten European countries could order shares at the offer price until 18 November. That route is closed. What is left is the open market, in dollars, at whatever price ANT trades for on the day you buy.
A note on who is writing this: Zune.Money is a portfolio tracker, not a broker or an adviser. We have no position to promote here, and nothing below is a recommendation to buy or avoid the stock.

What happened in the Anthropic IPO
The numbers are large even by 2026 standards. According to Al Jazeera's report on the debut, Anthropic sold 980 million Class A shares, raised about $81 billion before the over-allotment option, and called the deal the largest IPO on record. The first trade printed at $111.50, 34% above the offer price, before the stock gave back half of that gain into the close on a day when the Nasdaq fell 2.2%.
The valuation figure you see depends on what the source counts. Reports range from about $1.1 trillion (shares outstanding only) to about $1.5 trillion (fully diluted) at the $83 offer price. Both are real numbers. They just answer different questions.
Europe got a real slice for once. Bloomberg reported that about $1.1 billion of stock went to European retail investors, through brokers including Trade Republic, flatexDEGIRO, Scalable Capital, Revolut and eToro. Demand ran far ahead of supply, so most people who subscribed received only part of what they asked for.
Who could join the European retail offer
| Country group | Brokers named in the prospectus |
|---|---|
| Germany, France, Netherlands, Spain | Trade Republic, flatexDEGIRO, Scalable Capital, eToro, Revolut, Interactive Brokers |
| Ireland, Finland | Trade Republic, flatexDEGIRO, eToro, Revolut, Interactive Brokers |
| Denmark, Sweden | flatexDEGIRO, Nordnet, eToro, Revolut, Interactive Brokers |
| Norway | Nordnet, eToro, Revolut, Interactive Brokers |
| Switzerland | flatexDEGIRO, eToro, Saxo |
Banks such as ING, Saxo and Nordnet also took orders in some of these countries. Belgium, Italy, Austria, Portugal and Poland were not in the offer at all. If you live there, the open market was always your only route.
How to buy Anthropic stock in Europe, step by step
The process is the same at every major European broker:
- Log in to a broker with US market access. Degiro, Trade Republic, Interactive Brokers, Scalable Capital, eToro and Saxo all give you Nasdaq stocks.
- Search for ANT and check the listing. The ISIN is US03703U1079 and the exchange should read Nasdaq. Ignore leveraged certificates and "pre-IPO" tracker products with similar names.
- Use a limit order. ANT moved from $111.50 to below $96 within its first trading session. A market order in that kind of swing can fill several dollars away from the price you saw on screen.
- Decide how much before you open the order ticket. Pick an amount in euros that you could watch fall 30% without selling in a panic. New listings can do that in weeks.
- Record your entry price in euros. Your broker shows it in dollars. Your tax return and your real return are in euros.
If you already received an IPO allocation, you do not need to do anything. The shares settled into your account on 20 November at $83, and you can hold or sell them from day one. Lock-up periods apply to founders and insiders, not to retail buyers in the public offer.
What it costs to buy ANT on Degiro or Trade Republic
On a single order, the commission is small. The way your order is routed matters more.
| Broker | Cost per order | How it routes |
|---|---|---|
| Trade Republic | €1 flat | Fills through a German venue (LS Exchange), not Nasdaq directly |
| Degiro | ~€2 for US exchanges | Sends the order to the US market, plus a currency conversion cost |
| Interactive Brokers | ~$0.005 per share, $1 min | Routes directly to Nasdaq |
Trade Republic is cheapest on paper. But a German venue quoting a US stock during a volatile first week can show wider spreads than Nasdaq itself, and on a stock moving 15% in a session, the spread can cost more than the commission. If you buy Anthropic on Degiro, the €2 fee is only part of the picture: the Degiro fees breakdown covers the exchange connectivity charge and the AutoFX conversion cost that the headline number leaves out.
For a buy-and-hold investor placing one order, the difference between €1 and €2 does not matter. Paying a wide spread on a fast-moving stock does.
The currency side of an ANT position
ANT is priced in US dollars. Hold it in a euro portfolio and you hold EUR/USD exposure as well, whether you planned to or not.
A quick example. Say you buy €2,000 of ANT. Over a year the share price rises 12%, but the dollar falls 7% against the euro. Your euro gain is about 4%, not 12%. The move works the other way too: a stronger dollar adds to your return. We worked through the full maths in our piece on how EUR/USD swings change your returns.
You may already own some Anthropic
This is the part most "how to buy" guides skip. Amazon and Alphabet hold large stakes in Anthropic, mostly as non-voting Class N shares. If you own an S&P 500 or Nasdaq-100 ETF, or Amazon and Alphabet stock directly, part of your portfolio already moves with Anthropic's fortunes.
Adding ANT on top of that is a bigger bet on one AI company than it looks. Before you buy, check how much of your portfolio already sits in the large US tech names. Our guide on how to invest in AI stocks from Europe explains how to set an AI ceiling for your portfolio. The piece on ETF overlap and Magnificent 7 exposure shows how to measure what you already hold, and our article on how exposed your portfolio is to an AI bubble covers what that concentration means if sentiment turns.
What the prospectus says about risk
The S-1 prospectus is long, and a few points are worth reading before you place an order:
- Revenue is growing fast, profits are thin. Anthropic reported about $17 billion of revenue in Q3 2026, with a small operating loss of $567 million for the quarter. The headline net loss is much larger, but most of that is a non-cash charge tied to convertible notes.
- Compute commitments are huge. The company has committed roughly $900 billion to future purchases, mostly cloud and chip capacity, with contracts running for decades.
- Customer concentration. A small group of customers accounts for a large share of revenue.
- Public shareholders have little control. Anthropic is a public benefit corporation and a controlled company. The founders and the Long-Term Benefit Trust hold the votes that decide the board.
None of this tells you whether ANT is cheap or expensive. It tells you what you are buying: a company priced on growth that has not happened yet, run by people your shares cannot outvote. History is also not kind to hot IPOs on average. As our article on Trade Republic's IPO access explains, research by Jay Ritter shows US IPOs have trailed the market in the years after listing.
If you compare this listing to June's other blockbuster, the pattern looks familiar. Our guide on how to buy SpaceX stock (SPCX) in Europe covered a similar first-day pop, followed by months of a volatile share price. CNBC's IPO guide is a good summary of the deal terms if you want the US view.
Track ANT next to the rest of your portfolio
Buying ANT takes two minutes. Knowing what it does to your portfolio afterwards is harder. A single new US stock adds dollar exposure, adds to the tech weighting you may already carry through ETFs, and can swing your weekly result more than the rest of your holdings combined.
A portfolio tracker shows that in one view. Zune.Money imports your Degiro history from a CSV export (Degiro has no public API), adds positions from other brokers, and shows every holding in euros with your sector and country split. Upload your export through the Degiro portfolio tracker, add your ANT position, and see what share of your total it now represents.
Keep the position at a size you could hold through a bad quarter. A brand-new listing will give you more than one.
Frequently asked questions
Can I still get Anthropic shares at the $83 IPO price?
No. The European retail order window closed on 18 November 2026, and allocated shares were confirmed on the first trading day. Anyone buying now pays the Nasdaq market price, which opened well above $83 and closed day one at $97.17.
Is Anthropic stock listed on a European exchange?
No. Anthropic's Class A shares trade only on the Nasdaq Global Select Market under the ticker ANT. Some brokers fill orders through German venues that quote the stock, but the primary listing, and the price reference, is Nasdaq in US dollars.
Does Anthropic pay a dividend?
Anthropic has not announced a dividend. Like most newly listed growth companies, it is reinvesting its cash, so an ANT position adds nothing to portfolio income. Any return comes from the share price, measured in dollars and then converted to your home currency.
Do I get voting rights with Anthropic Class A shares?
Very limited ones. Anthropic is a controlled company. A single founder share carries a majority of the votes and the Long-Term Benefit Trust elects a majority of the board, so public Class A holders have little say over directors or major decisions.
Can I hold ANT in a French PEA or similar tax wrapper?
No. ANT is a US-listed share, and the French PEA only accepts European securities. Most EU tax-advantaged accounts have similar limits, so you would hold Anthropic in an ordinary securities account. Check your own country's rules with a tax adviser.


